Skip to main content
Top
Published in: Journal of Clinical Immunology 3/2017

01-04-2017 | Original Article

Gastrointestinal Manifestations in X-linked Agammaglobulinemia

Authors: Sara Barmettler, Iris M. Otani, Jasmit Minhas, Roshini S. Abraham, Yenhui Chang, Morna J. Dorsey, Zuhair K. Ballas, Francisco A. Bonilla, Hans D. Ochs, Jolan E. Walter

Published in: Journal of Clinical Immunology | Issue 3/2017

Login to get access

Abstract

Purpose

X-linked agammaglobulinemia is a primary humoral immunodeficiency characterized by hypogammaglobulinemia and increased susceptibility to infection. Although there is increased awareness of autoimmune and inflammatory complications in X-linked agammaglobulinemia (XLA), the spectrum of gastrointestinal manifestations has not previously been fully explored.

Methods

We present a case report of a family with two affected patients with XLA. Given the gastrointestinal involvement of the grandfather in this family, we performed a retrospective descriptive analysis of XLA patients with reported diagnoses of GI manifestations and inflammatory bowel disease (IBD) or enteritis registered at the United States Immunodeficiency Network, a national registry of primary immunodeficiencies.

Results

In this cohort of patients with XLA, we found that up to 35% had concurrent gastrointestinal manifestations, and 10% had reported diagnoses of IBD or enteritis. The most commonly reported mutations were missense, which have been associated with a less severe XLA phenotype in the literature. The severity of symptoms were wide ranging, and management strategies were diverse and mainly experimental.

Conclusions

Patients with XLA may require close monitoring with particular attention for GI manifestations including IBD and infectious enteritis. Further studies are needed to improve diagnosis and management of GI conditions in XLA patients.
Literature
2.
go back to reference Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34(6):627–32.CrossRefPubMedPubMedCentral Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34(6):627–32.CrossRefPubMedPubMedCentral
3.
go back to reference Lee PPW, Chen T-X, Jiang L-P, Chan K-W, Yang W, Lee B-W, et al. Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia. J Clin Immunol. 2010;30(1):121–31.CrossRefPubMed Lee PPW, Chen T-X, Jiang L-P, Chan K-W, Yang W, Lee B-W, et al. Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia. J Clin Immunol. 2010;30(1):121–31.CrossRefPubMed
4.
go back to reference Conley ME. Genetics of hypogammaglobulinemia: what do we really know ? Curr Opionion Immunol. 2010;21(5):466–71.CrossRef Conley ME. Genetics of hypogammaglobulinemia: what do we really know ? Curr Opionion Immunol. 2010;21(5):466–71.CrossRef
5.
go back to reference Conley ME, Fitch-Hilgenberg ME, Cleveland JL, Parolini O, Rohrer J. Screening of genomic DNA to identify mutations in the gene for Bruton’s tyrosine kinase. Hum Mol Genet. 1994;3(10):1751–6.CrossRefPubMed Conley ME, Fitch-Hilgenberg ME, Cleveland JL, Parolini O, Rohrer J. Screening of genomic DNA to identify mutations in the gene for Bruton’s tyrosine kinase. Hum Mol Genet. 1994;3(10):1751–6.CrossRefPubMed
6.
go back to reference Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. Bruton’s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol. 2001;114(1):141–9.CrossRefPubMed Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. Bruton’s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol. 2001;114(1):141–9.CrossRefPubMed
7.
go back to reference Tóth B, Volokha A, Mihas A, Pac M, Bernatowska E, Kondratenko I, et al. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study. Mol Immunol. 2009;46(10):2140–6.CrossRefPubMed Tóth B, Volokha A, Mihas A, Pac M, Bernatowska E, Kondratenko I, et al. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study. Mol Immunol. 2009;46(10):2140–6.CrossRefPubMed
8.
go back to reference Broides A, Yang W, Conley ME. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol Orlando Fla. 2006;118(2–3):195–200.CrossRef Broides A, Yang W, Conley ME. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol Orlando Fla. 2006;118(2–3):195–200.CrossRef
9.
go back to reference Jones A, Bradley L, Alterman L, Tarlow M, Thompson R, Kinnon C, et al. X linked agammaglobulinaemia with a “leaky” phenotype. Arch Dis Child. 1996;74(6):548–9.CrossRefPubMedPubMedCentral Jones A, Bradley L, Alterman L, Tarlow M, Thompson R, Kinnon C, et al. X linked agammaglobulinaemia with a “leaky” phenotype. Arch Dis Child. 1996;74(6):548–9.CrossRefPubMedPubMedCentral
10.
go back to reference López-Granados E, Pérez de Diego R, Ferreira Cerdán A, Fontán Casariego G, García Rodríguez MC. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J Allergy Clin Immunol. 2005;116(3):690–7.CrossRefPubMed López-Granados E, Pérez de Diego R, Ferreira Cerdán A, Fontán Casariego G, García Rodríguez MC. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J Allergy Clin Immunol. 2005;116(3):690–7.CrossRefPubMed
11.
go back to reference Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2013;11(9):1050–63. Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2013;11(9):1050–63.
12.
go back to reference Al-Muhsen SZ. Gastrointestinal and hepatic manifestations of primary immune deficiency diseases. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc. 2010;16(2):66–74.CrossRef Al-Muhsen SZ. Gastrointestinal and hepatic manifestations of primary immune deficiency diseases. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc. 2010;16(2):66–74.CrossRef
13.
go back to reference Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46(10):1547–54.CrossRef Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46(10):1547–54.CrossRef
14.
go back to reference Meyers G, Ng Y-S, Bannock JM, Lavoie A, Walter JE, Notarangelo LD, et al. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc Natl Acad Sci U S A. 2011;108(28):11554–9.CrossRefPubMedPubMedCentral Meyers G, Ng Y-S, Bannock JM, Lavoie A, Walter JE, Notarangelo LD, et al. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc Natl Acad Sci U S A. 2011;108(28):11554–9.CrossRefPubMedPubMedCentral
15.
go back to reference Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990–1007.e3.CrossRefPubMedPubMedCentral Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990–1007.e3.CrossRefPubMedPubMedCentral
16.
go back to reference Bianco AM, Girardelli M, Tommasini A. Genetics of inflammatory bowel disease from multifactorial to monogenic forms. World J Gastroenterol. 2015;21(43):12296–310.CrossRefPubMedPubMedCentral Bianco AM, Girardelli M, Tommasini A. Genetics of inflammatory bowel disease from multifactorial to monogenic forms. World J Gastroenterol. 2015;21(43):12296–310.CrossRefPubMedPubMedCentral
17.
go back to reference Shah S, Terdiman J, Gundling K, Mahadevan U. Immunoglobulin therapy for refractory Crohn’s disease. Ther Adv Gastroenterol. 2014;7(2):99–102.CrossRef Shah S, Terdiman J, Gundling K, Mahadevan U. Immunoglobulin therapy for refractory Crohn’s disease. Ther Adv Gastroenterol. 2014;7(2):99–102.CrossRef
18.
go back to reference Rogosnitzky M, Danks R, Holt D. Intravenous immunoglobulin for the treatment of Crohn’s disease. Autoimmun Rev. 2012;12(2):275–80.CrossRefPubMed Rogosnitzky M, Danks R, Holt D. Intravenous immunoglobulin for the treatment of Crohn’s disease. Autoimmun Rev. 2012;12(2):275–80.CrossRefPubMed
19.
go back to reference Kaveri SV, Maddur MS, Hegde P, Lacroix-Desmazes S, Bayry J. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol. 2011;164(Suppl):2–5.CrossRefPubMedPubMedCentral Kaveri SV, Maddur MS, Hegde P, Lacroix-Desmazes S, Bayry J. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol. 2011;164(Suppl):2–5.CrossRefPubMedPubMedCentral
20.
21.
go back to reference Jasion VS, Burnett BP. Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans. Nutr J. 2015;14:22.CrossRefPubMedPubMedCentral Jasion VS, Burnett BP. Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans. Nutr J. 2015;14:22.CrossRefPubMedPubMedCentral
22.
go back to reference Van Arsdall M, Haque I, Liu Y, Rhoads JM. Is there a role for the enteral administration of serum-derived immunoglobulins in human gastrointestinal disease and pediatric critical care nutrition? Adv Nutr Bethesda Md. 2016;7(3):535–43.CrossRef Van Arsdall M, Haque I, Liu Y, Rhoads JM. Is there a role for the enteral administration of serum-derived immunoglobulins in human gastrointestinal disease and pediatric critical care nutrition? Adv Nutr Bethesda Md. 2016;7(3):535–43.CrossRef
Metadata
Title
Gastrointestinal Manifestations in X-linked Agammaglobulinemia
Authors
Sara Barmettler
Iris M. Otani
Jasmit Minhas
Roshini S. Abraham
Yenhui Chang
Morna J. Dorsey
Zuhair K. Ballas
Francisco A. Bonilla
Hans D. Ochs
Jolan E. Walter
Publication date
01-04-2017
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 3/2017
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-017-0374-x

Other articles of this Issue 3/2017

Journal of Clinical Immunology 3/2017 Go to the issue